Cellular and molecular technology

1
Cellular and molecular
technology:
to restore function
How to proceed?
2
Program cellular and molecular technology: to restore function
10.15h Prof. Dr. Hans Tanke (LUMC) – Welcome
10.20h Prof. Dr. Christine Mummery (LUMC) – Stem cell technology
10.45h Prof. Dr. Reno Debets (Erasmus MC) – T-cell therapy
11.10h Prof. Dr. Rob Hoeben (LUMC) – Gene Transfer
11.35h Prof. Dr. Piet Hein van der Graaf (LACDR) – Systems Pharmacology
12.00h Hans Tanke: How to proceed?
12.10h Jacqueline Ton: National and European funding opportunities for Cellular
and Molecular Technology in the coming year
12.15h Pitches by companies and/or researchers
12.30h Final remarks and closing.
3
Cellular and molecular
technology:
to restore function
Four programs in Medical Delta
“Imaging and Image Guided Medicine”
“Interventions and Care
“Vitality”
“Targeted Molecular Technology”
4
Cellular and molecular
technology:
to restore function
More focus:
• Concentrate on cellular and molecular
technology to restore function
• Stem cells and gene engineering
• Human Disease Model Technologies
• Drug development
5
Cellular and molecular
technology:
to restore function
Plans:
Topical meetings: 3-4 per year in DRL
Top speakers that introduce a theme
50+ participants (triple helix)
Volunteers for program committee
(DRL, Academia and Industry)
Open to all (not only Medical Delta)
6
Cellular and molecular
technology:
to restore function
Leave you name and address:
[email protected]
[email protected]
7
Program cellular and molecular technology: to restore function
10.15h Prof. Dr. Hans Tanke (LUMC) – Welcome
10.20h Prof. Dr. Christine Mummery (LUMC) – Stem cell technology
10.45h Prof. Dr. Reno Debets (Erasmus MC) – T-cell therapy
11.10h Prof. Dr. Rob Hoeben (LUMC) – Gene Transfer
11.35h Prof. Dr. Piet Hein van der Graaf (LACDR) – Systems Pharmacology
12.00h Hans Tanke: How to proceed?
12.10h Jacqueline Ton: National and European funding opportunities for Cellular
and Molecular Technology in the coming year
12.15h Pitches by companies and/or researchers
12.30h Final remarks and closing.